Grant: Idea to Innovation
McGill University
$123,955.00
New hybrid anti-adhesive biomaterials for medical devices industry
FY 2009-10
Summary
We have demonstrated that cranberry derived proanthocyanidins (PACs) have the potential to reduce the occurrence and duration of catheter-associated infection by preventing bacterial adhesion to catheter surfaces and promoting mammalian cell health. The aim of the proposed research is to develop an effective method to integrate cranberry-derived PACs into biomaterial matrices that do not undermine the anti-adhesive properties of the PACs for the prevention of biomaterial related infections. The research will focus on impregnating cranberry PACs in polymeric materials to be used as medical catheters; i.e., urinary catheters and central line catheters. These materials will be based on (1) silicone elastomers, a commonly used polymer in catheter development, (2) elastomeric blends of methacrylate/styrene-isopene-styrene copolymers, and (3) degradable matrices based on poly(lactic acid-co-glycolic acid) that may be used as coatings. Once impregnated into these polymer matrices, the PACs must retain their biological activity. We will therefore need to evaluate the anti-adhesive properties of these new hybrid polymeric materials against a range of infectious organisms. This research will generate incremental and valuable data to design a new generation of hybrid anti-adhesive biomaterials (HAABs) for the medical catheters industry. In 2005, the revenue from the medical devices market for antimicrobial coatings totaled $US 80.4 million and it is expected to reach $US 249.4 million in 2012 at a compound annual growth rate of 17.6% during the period 2005 to 2012. The catheter segment is expected to see huge growth in the medical devices industry as safety and protection from microbes are of primary concern in the use of these devices. The development of HAABs will be done with partner organizations who have a significant interest in the potential for their commercialization; namely medical device technology firms and cranberry producers/marketers.
Program
Idea to Innovation
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
380670-2009
Name nom
Tufenkji, Nathalie
Department département
Chemical Engineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2009
Award amount
123955
Program id
I2IPJ
Program nane en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
1
Nb partie
1
Application title
New hybrid anti-adhesive biomaterials for medical devices industry
Keyword
NA
Application summary
We have demonstrated that cranberry derived proanthocyanidins (PACs) have the potential to reduce the occurrence and duration of catheter-associated infection by preventing bacterial adhesion to catheter surfaces and promoting mammalian cell health. The aim of the proposed research is to develop an effective method to integrate cranberry-derived PACs into biomaterial matrices that do not undermine the anti-adhesive properties of the PACs for the prevention of biomaterial related infections. The research will focus on impregnating cranberry PACs in polymeric materials to be used as medical catheters; i.e., urinary catheters and central line catheters. These materials will be based on (1) silicone elastomers, a commonly used polymer in catheter development, (2) elastomeric blends of methacrylate/styrene-isopene-styrene copolymers, and (3) degradable matrices based on poly(lactic acid-co-glycolic acid) that may be used as coatings. Once impregnated into these polymer matrices, the PACs must retain their biological activity. We will therefore need to evaluate the anti-adhesive properties of these new hybrid polymeric materials against a range of infectious organisms. This research will generate incremental and valuable data to design a new generation of hybrid anti-adhesive biomaterials (HAABs) for the medical catheters industry. In 2005, the revenue from the medical devices market for antimicrobial coatings totaled $US 80.4 million and it is expected to reach $US 249.4 million in 2012 at a compound annual growth rate of 17.6% during the period 2005 to 2012. The catheter segment is expected to see huge growth in the medical devices industry as safety and protection from microbes are of primary concern in the use of these devices. The development of HAABs will be done with partner organizations who have a significant interest in the potential for their commercialization; namely medical device technology firms and cranberry producers/marketers.